Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Changchun BCHT Biotechnology

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 1
Rounds per year 0.06
Lead investments 0
Key employees Soon

Areas of investment

  • Medical
  • Biotechnology
  • Health Care
Summary

Changchun BCHT Biotechnology appeared to be the Corporate Investor, which was created in 2004. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Changchun.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Mucosis. For fund there is no match between the location of its establishment and the land of its numerous investments - The Netherlands. We can highlight the next thriving fund investment areas, such as Health Care, Medical.

The typical case for the fund is to invest in rounds with 5 participants. Despite the Changchun BCHT Biotechnology, startups are often financed by NV NOM, MedSciences Capital, BioGeneration Ventures. The meaningful sponsors for the fund in investment in the same round are Utrecht Holdings, NV NOM, MedSciences Capital. In the next rounds fund is usually obtained by Wellcome Trust, BioGeneration Ventures.

The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2014.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Changchun BCHT Biotechnology:
Typical Co-investors
Changchun BCHT Biotechnology is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Changchun BCHT Biotechnology:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
a2b SGPS -
Dongyang Wenhan China, Jinhua, Zhejiang
DXC Technology Arlington, United States, Virginia
Houxing Capital -
Leclerc family -
Linhao Touzi China, Shanghai
Rihe Keji Beijing, China, Haidian
Shenqiankun Touzi China, Guangdong, Shenzhen
Woodstock -

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Changchun BCHT Biotechnology?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 6M
Rounds per year 0.06
Peak activity year 2014
Lead investments 0
Group Appearance index 1.00
Crunchbase icon

Content report

The following text will be sent to our editors: